AG0052P8

81403-68-1 | Alfuzosin Hydrochloride

AG0052P8

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	81403-68-1
Catalog Number	AG0052P8(AGN-PC-07Y47H)
Chemical Name	Alfuzosin Hydrochloride
IUPAC Name	N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide;hydrochloride
InChI	InChI=1S/C19H27N5O4.ClH/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19;/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23);1H
InChI Key	YTNKWDJILNVLGX-UHFFFAOYSA-N
MDL Number	MFCD00879135
Molecular Formula	C19H28ClN5O4
Molecular Weight	425.9097
SMILES	O=C(C1OCCC1)NCCCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)C.Cl
Synonyms	Alfetim, alfusozine, alfuzosin, alfuzosin hydrochloride, alphuzosine, Benestan, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide, Urion, UroXatral, Xatral, Alfuzosin Hydrochloride, 81403-68-1, Alfuzosin HCl, Uroxatral, Xatral, Urion, Alfoten, Alfuzosin (hydrochloride), SL 77499-10, SL 77 499-10, SL-7749910, Alfuzosin hydrochloride (Uroxatral), MFCD00879135, Alfetim, (+-)-N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furamide monohydrochloride, DSSTox_CID_25514, DSSTox_RID_80924, DSSTox_GSID_45514, SL-77499-10, Xatral Retard, Xatral OD, Xatral SR, Xatral XL, CHEBI:32286, Uroxatral (TN), 2-Furancarboxamide, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-, monohydrochloride (+-)-, C19H27N5O4, Alfuzosin hydrochloride [USAN], N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)tetrahydrofuran-2-carboxamide hydrochloride, N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl), SR-01000759345, N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide hydrochloride, n-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride, Alfuzosin hydrochloride (JAN/USAN), Alfuzosin hydrochloride [USAN:USP], Alfuzosin-hydrochloride, Uroxatral hydrochloride, SL-77499, Alfuzosin hydrochloride;, AC1L2GRP, AC1Q5PED, NCGC00016946-01, SL77.0499-10, CAS-81403-68-1, SL-77.0499-10, Alfuzosin Hydrochloride,(S), CHEMBL1723, C19H28ClN5O4, n-{3-[(4-amino-6,7-dimethoxychinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamidhydrochlorid, SCHEMBL179910, DTXSID3045514, CTK8F7637, HY-B0192A, YTNKWDJILNVLGX-UHFFFAOYSA-N, BCPP000417, HMS1569A05, KS-00000XK8, Tox21_110701, Tox21_500224, s1409, (methyl)amino)propyl)tetrahydrofuran-2, AKOS015966770, Tox21_110701_1, AC-1116, API0001407, BCP9000271, CCG-213373, CS-2087, LP00224, NCGC00095152-09, NCGC00260909-01, AS-14240, AT-12271, BC677639, CC-23835, K448, LS-70107, N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide hydrochloride, N-[3-[4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride, AB0008072, AB2000094, A2591, AK00451977, FT-0630890, SW196913-4, D01692, Alfuzosin hydrochloride, >=98% (HPLC), solid, 403A681, SR-01000759345-5, Alfuzosin hydrochloride, European Pharmacopoeia (EP) Reference Standard, Alfuzosin hydrochloride, United States Pharmacopeia (USP) Reference Standard, Alfuzosin for peak identification, European Pharmacopoeia (EP) Reference Standard, Alfuzosin for system suitability A, European Pharmacopoeia (EP) Reference Standard, Alfuzosin for system suitability, European Pharmacopoeia (EP) Reference Standard, Alfuzosin hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, 4-Amino-6,7-dimethoxy-2-[methyl[3-[(tetrahydro-2-furoyl)amino]propyl]amino]quinazoline Hydrochloride, N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]propyl]tetrahydro-2-furancarboxamide Hydrochloride, N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]propyl]tetrahydro-2-furancarboxamide Hydrochloride / 4-Amino-6,7-dimethoxy-2-[methyl[3-[(tetrahydro-2-furoyl)amino]propyl]amino]quinazoline Hydrochloride, N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolynyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride, alfuzosin, alfusozine, alphuzosine, Benestan, -carboxamide hydrochloride, D0H1YQ, UNII-75046A1XTN, C19H27N5O4.ClH, Uroxatral, Alfuzosin hydrochloride, 75046A1XTN, CID71764, C19-H27-N5-O4.Cl-H, AR-1K4672, RW2757, CS-O-00515, Alfuzosin hydrochloride, 99% - 1G 1g, C047638, 2682-98-6, 81403-80-7, HCl, N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide,

Complexity	511
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	425.183g/mol
Formal Charge	0
Heavy Atom Count	29
Hydrogen Bond Acceptor Count	8
Hydrogen Bond Donor Count	3
Isotope Atom Count	0
Molecular Weight	425.914g/mol
Monoisotopic Mass	425.183g/mol
Rotatable Bond Count	8
Topological Polar Surface Area	112A^2
Undefined Atom Stereocenter Count	1
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302
Packing Group
Precautionary statements	P280-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number